We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Hemofiltration for Contrast-Induced Nephropathy

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2005 by Nara Medical University.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00158080
First Posted: September 12, 2005
Last Update Posted: December 9, 2005
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Nara Medical University
  Purpose
Contrast-induced acute renal failure can be prevented with hemofiltration which is performed during cardiac catheterization

Condition Intervention
Chronic Kidney Disease Cardiac Catheterization Procedure: hemofiltration

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Prevention of Contrast-Induced Nephropathy by Real-Time Hemofiltration

Resource links provided by NLM:


Further study details as provided by Nara Medical University:

Primary Outcome Measures:
  • Prevention of contrast-induced acute renal failure, Elevation of serum creatinine

Secondary Outcome Measures:
  • Need for hemodialysis

Estimated Enrollment: 100
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients with serum creatinine>2.0mg/dl and/or GFR<50ml/min

Exclusion Criteria:

  • Emergent cardiac catheterization
  • Patients on chronic dialysis
  • Patients with HYHA>III heart failure
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00158080


Contacts
Contact: Koji Harada, MD +81-744-22-3051 ext 3411 kzharada@naramed-u.ac.jp

Locations
Japan
First Dept of InternalMedicine, Nara Medical University Recruiting
Kashihara, Nara, Japan, 634-8522
Contact: Koji Harada, MD    +81-744-22-3051 ext 3411    kzharada@naramed-u.ac.jp   
Sponsors and Collaborators
Nara Medical University
Investigators
Study Director: Yoshihiko Saito, MD, PhD Nara Medical University
  More Information

Publications:
ClinicalTrials.gov Identifier: NCT00158080     History of Changes
Other Study ID Numbers: K0001
First Submitted: September 7, 2005
First Posted: September 12, 2005
Last Update Posted: December 9, 2005
Last Verified: September 2005

Additional relevant MeSH terms:
Kidney Diseases
Renal Insufficiency, Chronic
Urologic Diseases
Renal Insufficiency